Team:TU-Delft

From 2012.igem.org

(Difference between revisions)
Line 73: Line 73:
<!-- end logo photos -->
<!-- end logo photos -->
-
<hr/>
+
<table class="summary">
-
<p style="color:#2ab117; background-color:gold;" ><strong> Advanced to the World Championship Jamboree!! </strong></p>
+
<tr class="summary">
-
<p>We are very proud to announce that our team is advancing to the World Championship Jamboree! At the Europe Jamboree we have earned a gold medal and won the Meeting of Young Minds award! <br/><b>To support our Boston adventure please click here: <a href="http://www.cafepress.com/dd/70975437" target="_blank">CafePress</a> or visit our crowd funding page by clicking <a href="https://2012.igem.org/Team:TU-Delft/crowdfunding" target="_blank">here</a></p></b>.
+
<td class="summary" style="font-size:110%;">
-
<hr/>
+
<strong style="font-size:120%;">The Challenge</strong><br/>
 +
<br />
 +
<p>Biological drugs such as hormones, enzymes, cytokines or antibodies are increasingly used to treat different diseases. Due to systemic administration, these drugs often have adverse effects. Additionally, the high cost of biopharmaceuticals imposes a heavy burden on health systems.</p>
 +
<p>We aimed to use the principles of synthetic biology to develop an advanced and safe method of <i>in situ</i> production of biological drugs to increase the quality of patients' lives. This system should increase compliance to therapy, decreas the number of required invasive drug administrations and enable advanced multistage therapy while local administration could reduce the side effects. </p>
 +
<p>We addressed this challenge by implementing microencapsulated engineered mammalian cells that can be regulated from the outside to produce different therapeutics. This system should be effective, reliable, safe and potentially more cost-effective.</p>
 +
</td>
 +
</tr>
 +
</table>
<h2><i>Snifferomyces</i>: A Tuberculosis Screening Automaton</h2>
<h2><i>Snifferomyces</i>: A Tuberculosis Screening Automaton</h2>

Revision as of 14:41, 25 October 2012

Menu
TUDelft -Leiden iGEM 2012
close
The Challenge

Biological drugs such as hormones, enzymes, cytokines or antibodies are increasingly used to treat different diseases. Due to systemic administration, these drugs often have adverse effects. Additionally, the high cost of biopharmaceuticals imposes a heavy burden on health systems.

We aimed to use the principles of synthetic biology to develop an advanced and safe method of in situ production of biological drugs to increase the quality of patients' lives. This system should increase compliance to therapy, decreas the number of required invasive drug administrations and enable advanced multistage therapy while local administration could reduce the side effects.

We addressed this challenge by implementing microencapsulated engineered mammalian cells that can be regulated from the outside to produce different therapeutics. This system should be effective, reliable, safe and potentially more cost-effective.

Snifferomyces: A Tuberculosis Screening Automaton


The 2012 project of the TU Delft iGEM team, draws inspiration from the sniffer rats which can be trained to sniff out unexploded landmines and tuberculosis. Tuberculosis infects around 8 million people a year and kills approximately 2 million. Drugs to treat tuberculosis have been around for a long time, so a rapid diagnosis system can help curb the spread of the disease. This year our team takes the first steps to make for this problem a screening olfactory automation!




Do not forget to get our app at your phone!! Stay informed about all the updates in our wiki through your android !! To download it press here

You can also find us on facebook!

Our Sponsors